Gensight Biologics SA
PAR:SIGHT

Watchlist Manager

Gensight Biologics SA

PAR:SIGHT

Watchlist

Dividends

Discount Rate

Price: 0.305 EUR -1.61% Market Closed

Market Cap: 35.1m EUR

Have any thoughts about
Gensight Biologics SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

Add Price Alert

Price Target:

Last Price: 0.305 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

SIGHT Alert

Gensight Biologics SA

0.305

-0.005 (-1.61%)

52 Week Range	0.2815 0.522
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Gensight Biologics SA

What unique competitive advantages
does Gensight Biologics SA hold over its rivals?

What risks and challenges
does Gensight Biologics SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Gensight Biologics SA.

What unique competitive advantages
does Gensight Biologics SA hold over its rivals?

What risks and challenges
does Gensight Biologics SA face in the near future?

Has there been any significant insider trading activity
in Gensight Biologics SA recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Gensight Biologics SA.

Provide P/S
for Gensight Biologics SA.

Provide P/E
for Gensight Biologics SA.

Provide P/OCF
for Gensight Biologics SA.

Provide P/FCFE
for Gensight Biologics SA.

Provide P/B
for Gensight Biologics SA.

Provide EV/S
for Gensight Biologics SA.

Provide EV/GP
for Gensight Biologics SA.

Provide EV/EBITDA
for Gensight Biologics SA.

Provide EV/EBIT
for Gensight Biologics SA.

Provide EV/OCF
for Gensight Biologics SA.

Provide EV/FCFF
for Gensight Biologics SA.

Provide EV/IC
for Gensight Biologics SA.

Show me price targets
for Gensight Biologics SA made by professional analysts.

What are the Revenue projections
for Gensight Biologics SA?

How accurate were the past Revenue estimates
for Gensight Biologics SA?

What are the Net Income projections
for Gensight Biologics SA?

How accurate were the past Net Income estimates
for Gensight Biologics SA?

What are the EPS projections
for Gensight Biologics SA?

How accurate were the past EPS estimates
for Gensight Biologics SA?

What are the EBIT projections
for Gensight Biologics SA?

How accurate were the past EBIT estimates
for Gensight Biologics SA?

Compare the revenue forecasts
for Gensight Biologics SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Gensight Biologics SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Gensight Biologics SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Gensight Biologics SA compared to its peers.

Compare the P/E ratios
of Gensight Biologics SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Gensight Biologics SA with its peers.

Analyze the financial leverage
of Gensight Biologics SA compared to its main competitors.

Show all profitability ratios
for Gensight Biologics SA.

Provide ROE
for Gensight Biologics SA.

Provide ROA
for Gensight Biologics SA.

Provide ROIC
for Gensight Biologics SA.

Provide ROCE
for Gensight Biologics SA.

Provide Gross Margin
for Gensight Biologics SA.

Provide Operating Margin
for Gensight Biologics SA.

Provide Net Margin
for Gensight Biologics SA.

Provide FCF Margin
for Gensight Biologics SA.

Show all solvency ratios
for Gensight Biologics SA.

Provide D/E Ratio
for Gensight Biologics SA.

Provide D/A Ratio
for Gensight Biologics SA.

Provide Interest Coverage Ratio
for Gensight Biologics SA.

Provide Altman Z-Score Ratio
for Gensight Biologics SA.

Provide Quick Ratio
for Gensight Biologics SA.

Provide Current Ratio
for Gensight Biologics SA.

Provide Cash Ratio
for Gensight Biologics SA.

What is the historical Revenue growth
over the last 5 years for Gensight Biologics SA?

What is the historical Net Income growth
over the last 5 years for Gensight Biologics SA?

What is the current Free Cash Flow
of Gensight Biologics SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Gensight Biologics SA.

EV/S
Enterprise Value to Sales

18.8

Current

39.4

Median

7.7

Industry

Lower than median

Higher than industry value

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S

18.8

Enterprise Value

44.2m EUR

Revenue

2.4m EUR

All Countries

Forward Multiples

			Market Cap	EV/S
FR		Gensight Biologics SA PAR:SIGHT	35.1m EUR	18.8
FR		Pharnext SCA OTC:PNEXF	6T USD	37 984 230.1
US		Abbvie Inc NYSE:ABBV	316.8B USD	6.6
US		Amgen Inc NASDAQ:AMGN	145.1B USD	5.8
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	119B USD	10.5
US		Gilead Sciences Inc NASDAQ:GILD	113.2B USD	3.8
US	E	Epizyme Inc F:EPE	94.1B EUR	1 856.4
AU		CSL Ltd ASX:CSL	135.4B AUD	6.6
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	82.7B USD	5.4
US	S	Seagen Inc F:SGT	39.3B EUR	17.3
NL		argenx SE XBRU:ARGX	34.3B EUR	17


FR		Gensight Biologics SA PAR:SIGHT	Average EV/S: 3 453 288.9 18.8
FR		Pharnext SCA OTC:PNEXF	37 984 230.1
US		Abbvie Inc NYSE:ABBV	6.6
US		Amgen Inc NASDAQ:AMGN	5.8
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	10.5
US		Gilead Sciences Inc NASDAQ:GILD	3.8
US	E	Epizyme Inc F:EPE	1 856.4
AU		CSL Ltd ASX:CSL	6.6
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	5.4
US	S	Seagen Inc F:SGT	17.3
NL		argenx SE XBRU:ARGX	17

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/S

12.3

2-Years Forward

EV/S

9.1

3-Years Forward

EV/S

15.1

Gensight Biologics SA
PAR:SIGHT

EV/S
Enterprise Value to Sales

EV/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Gensight Biologics SA PAR:SIGHT

EV/S Enterprise Value to Sales

EV/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Gensight Biologics SA
PAR:SIGHT

EV/S
Enterprise Value to Sales